Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 3, 2012, Pages 336-341

  Khawcharoenporn, T ^a   Apisarnthanarak, Anucha ^a   Manosuthi, W ^b   Sungkanuparph, S ^c   Mundy, L M ^d  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d LM Mundy LLC   (United States)

Author keywords

Antiretroviral therapy; Latent tuberculosis; Screening

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; THAILAND; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; ISONIAZID; MALE; PROSPECTIVE STUDIES; THAILAND; TIME FACTORS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 84857260766     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0402     Document Type: Article

References (22)

1. World Health Organization. WHO report 2010. Global tuberculosis control. WHO/HTM/TB/2010.7. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/ publications/2010/9789241564069-eng.pdf Accessed November 2011.
2. Aït-Khaled N, Alarcon E, Bissell K, et al. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis 2009; 13: 927-935.
3. World Health Organization. Meeting report. TB and HIV: accelerating the implementation of collaborative TB-HIV activities in the WHO European Region. 16-17 July, 2010, Vienna, Austria. WHO/HTM/TB/2010.9. Geneva, Switzerland: WHO, 2010. http://whqlibdoc.who.int/hq/2010/WHO-HTM-TB-2010.9-eng.pdf Accessed November 2011.
4. Golub J E, Saraceni V, Cavalcante S C, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007; 21: 1441-1448. (Pubitemid 46988004)
5. Whalen C C, Johnson J L, Okwera A, et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-908.
6. Mwinga A, Hosp M, Godfrey-Faussett P, et al. Twice weekly tuberculosis preventive therapy in HIV infection in Zambia. AIDS 1998; 12: 2447-2457. (Pubitemid 28558603)
7. Pape J W, Jean S S, Ho J L, et al. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-272. (Pubitemid 23224420)
8. Elzi L, Schlegel M, Weber R, Hafner A, Johnson W D Jr. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis 2007; 44: 94-102. (Pubitemid 44968992)
9. World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings, 2011, Geneva Switzerland: WHO, 2011. http://whqlibdoc.who.int/publications/2011/9789241500708-eng.pdf Accessed November 2011.
10. Sungkanuparph S, Anekthananon T, Hiransuthikul N, et al. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008. J Med Assoc Thai 2008; 91: 1925-1935.
11. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, Woeltje K F, Fraser V J. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis 2011; 15: 14-23.
12. Pouchot J, Grasland A, Collet C, Coste J, Esdaile J M, Vinceneux P. Reliability of tuberculin skin test measurement. Ann Intern Med 1997; 126: 210-214. (Pubitemid 27061574)
13. Khawcharoenporn T, Apisarnthanarak A, Mundy L M. Assessment of risk for pulmonary tuberculosis after non-reactive tuberculin skin testing among patients with HIV infection in a resource-limited setting. Int J STD AIDS 2008; 19: 843-847.
14. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005; 172: 1169-1227.
15. Kitkungvan D, Apisarnthanarak A, Laowansiri P, Mundy L M. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense. HIV Med 2008; 9: 636-641.
16. Samandari T, Agizew T B, Nyirenda S, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377: 1588-1598.
17. Charalambous S, Grant A D, Innes C, et al. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. AIDS 2010; 24 (Suppl 5): S5-S13.
18. Frigati L J, Kranzer K, Cotton M F, Schaaf H S, Lombard C J, Zar H J. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax 2011; 66: 496-501.
19. Lester R, Hamilton R, Charalambous S, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS 2010; 24 (Suppl 5): S45-S48.
20. Durovni B, Cavalcante S C, Saraceni V, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS 2010; 24 (Suppl 5): S49-S56.
21. Cattamanchi A, Smith R, Steingart K R, et al. Interferongamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 2011; 56: 230-238.
22. Cain K P, McCarthy K D, Heilig C M, et al. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010; 362: 707-716.